Inventor · disambiguated record
Hans-Peter Schwarz
Also filed as: SCHWARZ HANS P · SCHWARZ HANS-PETER
125 granted patents·35 pending applications·1,561 citations·filing 1990–2024
99Inventor score
Top patents by PatentIndex Score
160 records- 0197US10758599B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2019·Granted Sep 1, 2020·10 cites·28 claims
- 0297US6224862B1Pharmaceutical preparation for treating blood coagulation disordersBAXTER AG·Filed 2000·Granted May 1, 2001·88 cites·4 claims
- 0395US7033590B1Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2000·Granted Apr 25, 2006·47 cites·22 claims
- 0494US11191837B2Recombinant VWF formulationsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Dec 7, 2021·9 cites·12 claims
- 0594US8623612B2Method for testing treatment of ADAMTS13 deficiencyBAXTER INT·Filed 2013·Granted Jan 7, 2014·10 cites·21 claims
- 0694US2025099559A1Stabilized liquid and lyophilized adamts13 formulationsTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0793US9110085B2Methods of testing effectiveness of a treatment for thromobotic thrombocytopenic purpura by measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factorBAXTER INT·Filed 2013·Granted Aug 18, 2015·8 cites·17 claims
- 0893US8304524B2Manufacture of factor H (FH) and FH-derivatives from plasmaBAIRSTOW SHAWN F·Filed 2010·Granted Nov 6, 2012·35 cites·17 claims
- 0992US11136350B2Method to produce an immunoglobulin preparation with improved yieldTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 5, 2021·9 cites·23 claims
- 1092US10209263B2Methods of measuring adamts 13 activityBAXALTA INC·Filed 2016·Granted Feb 19, 2019·5 cites·32 claims
- 1191US10238720B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2018·Granted Mar 26, 2019·5 cites·30 claims
- 1291US9084743B2Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereofTESCHNER WOLFGANG·Filed 2010·Granted Jul 21, 2015·32 cites·29 claims
- 1391US8623352B2Stabilized liquid and lyophilized ADAMTS13 formulationsMATTHIESSEN PETER·Filed 2010·Granted Jan 7, 2014·13 cites·50 claims
- 1491US8173597B2Modified recombinant factor VIII and von Willebrand factor and methods of useSCHWARZ HANS-PETER·Filed 2008·Granted May 8, 2012·9 cites·15 claims
- 1591US7501117B2Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLVBAXTER INNOVATIONS GMBH·Filed 2005·Granted Mar 10, 2009·12 cites·8 claims
- 1691US6926894B2Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLVBAXTER AG·Filed 2001·Granted Aug 9, 2005·39 cites·27 claims
- 1791US5891843APharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its useIMMUNO AKTIENGESLLSCHAFT·Filed 1996·Granted Apr 6, 1999·83 cites·13 claims
- 1890US10738107B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggsBAXALTA INC·Filed 2016·Granted Aug 11, 2020·4 cites·11 claims
- 1990US8546548B2Method to produce a highly concentrated immunoglobulin preparation for subcutaneous useTESCHNER WOLFGANG·Filed 2010·Granted Oct 1, 2013·17 cites·16 claims
- 2090US7279161B2Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2005·Granted Oct 9, 2007·6 cites·9 claims
- 2190US6919311B2Factor VII polypeptide having factor VII:C activitySANQUIN BLOEDVOORZIENING·Filed 2001·Granted Jul 19, 2005·33 cites·8 claims
- 2290US5866122APharmaceutical preparation for treating blood coagulation disordersIMMUNO AG·Filed 1997·Granted Feb 2, 1999·59 cites·45 claims
- 2389US9937244B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2017·Granted Apr 10, 2018·4 cites·32 claims
- 2489US9708391B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2016·Granted Jul 18, 2017·3 cites·20 claims
- 2589US9572778B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2016·Granted Feb 21, 2017·4 cites·54 claims
- 2689US8772462B2Removal of serine proteases by treatment with finely divided silicon dioxideTESCHNER WOLFGANG·Filed 2011·Granted Jul 8, 2014·5 cites·18 claims
- 2789US6013620APharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its useBAXTER AG·Filed 1997·Granted Jan 11, 2000·79 cites·25 claims
- 2888US10125189B2Method to produce a highly concentrated immunoglobulin preparation for subcutaneous useBAXALTA INC·Filed 2015·Granted Nov 13, 2018·7 cites·18 claims
- 2988US9488651B2Methods of measuring ADAMTS 13 activityBAXALTA INC·Filed 2014·Granted Nov 8, 2016·3 cites·18 claims
- 3088US9468675B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2014·Granted Oct 18, 2016·4 cites·20 claims
- 3188US8921520B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXTER INT·Filed 2012·Granted Dec 30, 2014·3 cites·21 claims
- 3288US8785139B2Modification-dependent activity assaysWEBER ALFRED·Filed 2012·Granted Jul 22, 2014·15 cites·28 claims
- 3388US6017891AStable preparation for the treatment of blood coagulation disordersBAXTER AG·Filed 1997·Granted Jan 25, 2000·78 cites·27 claims
- 3487US12178861B2Stabilized liquid and lyophilized ADAMTS13 formulationsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Dec 31, 2024·0 cites·20 claims
- 3587US8993734B2Method to produce an immunoglobulin preparation with improved yieldBRUCKSCHWAIGER LEOPOLD·Filed 2010·Granted Mar 31, 2015·14 cites·47 claims
- 3687US5854403AMethod for isolation of highly pure von Willebrand FactorIMMUNO AG·Filed 1996·Granted Dec 29, 1998·53 cites·16 claims
- 3787US2024117009A1Removal of serine proteases by treatment with finely divided silicon dioxideTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 3886US9175068B2Method to produce a highly concentrated immunoglobulin preparation for subcutaneous useBAXTER INT·Filed 2013·Granted Nov 3, 2015·8 cites·24 claims
- 3986US8415114B2Methods of measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor and uses thereofVARADI KATALIN·Filed 2009·Granted Apr 9, 2013·8 cites·18 claims
- 4085US8940877B2Method to produce an immunoglobulin preparation with improved yieldBAXTER INT·Filed 2012·Granted Jan 27, 2015·7 cites·27 claims
- 4185US8377375B2Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactorsBAXTER INT·Filed 2011·Granted Feb 19, 2013·7 cites·24 claims
- 4284US7968293B2IVIG modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's diseaseBAXTER INT·Filed 2008·Granted Jun 28, 2011·10 cites·13 claims
- 4384US5304383APharmaceutical preparation based on Lys-plasminogenIMMUNO AG·Filed 1991·Granted Apr 19, 1994·50 cites·13 claims
- 4483US9512198B2FVIII peptides for immune tolerance induction and immunodiagnosticsBAXALTA INC·Filed 2015·Granted Dec 6, 2016·5 cites·20 claims
- 4583US8114633B2Methods for differentiating plasma-derived protein from recombinant protein in a sampleWEBER ALFRED·Filed 2008·Granted Feb 14, 2012·7 cites·17 claims
- 4682US9075069B2Measurement of autoantibodies at low conductivity with increased sensitivityBAXTER INT·Filed 2012·Granted Jul 7, 2015·4 cites·26 claims
- 4782US8889838B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXTER INT·Filed 2013·Granted Nov 18, 2014·3 cites·21 claims
- 4882US7993580B2Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactorsBAXTER INT·Filed 2004·Granted Aug 9, 2011·32 cites·23 claims
- 4982US7807435B2Method for the purification of alpha-1 proteinase inhibitor (a1PI)BAXTER INT·Filed 2005·Granted Oct 5, 2010·6 cites·14 claims
- 5081US8962912B2Transgenic non-human animals expressing human blood clotting factors and uses thereofSASGARY MARIA·Filed 2011·Granted Feb 24, 2015·11 cites·11 claims
Showing the top 50 of 160 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →